SARS-CoV-2 saliva testing is a useful tool for Covid-19 diagnosis.

SARS-CoV-2 saliva testing is a useful tool for Covid-19 diagnosis.
复制标题

DOI:
10.1016/j.jviromet.2021.114241
复制
发表时间:
2021-10
影响因子:
3.1
通讯作者:
Levi JE
Levi JE
中科院分区:
医学4区
文献类型:
--
作者:
de Oliveira CM;Brochi L;Scarpelli LC;Lopes ACW;Levi JE

文献摘要

参考文献

被引文献

相似文献

SARS-CoV-2是2019冠状病毒病(COVID-19)的病原,根据世界卫生组织的建议,主要通过RT-PCR方法从上呼吸道标本中检测。口腔/鼻咽拭子可能使患者感到不舒服,需要训练有素的医护人员,并可能产生气溶胶,增加院内感染的风险。在这项研究中,我们描述了唾液样本中两种不提取SARS-CoV-2 RNA的单次RT-PCR方法,并将结果与来自400例患者的配对口腔/鼻咽拭子样本进行了比较。与口腔/鼻咽拭子方案相比,两种唾液方案显示出实质性的一致性。唾液协议阳性率随病程的延长而增加。其中一种唾液方案的95%检出限为9441拷贝/mL。我们的研究结果支持这样的结论,即使用自采集唾液标本进行无RNA提取的RT-PCR可以替代鼻咽拭子,特别是在症状发作的早期阶段。
SARS-CoV-2 is the etiologic agent of coronavirus disease 2019 (COVID-19) and is mainly detected by RT-PCR methods from upper respiratory specimens, as recommended by the World Health Organization. Oro/nasopharyngeal swabbing can be discomfortable to the patients, requires trained healthcare personnel and may generate aerosol, increasing the risk of nosocomial infections. In this study, we describe two SARS-CoV-2 RNA extraction-free single RT-PCR protocols on saliva samples and compared the results with the paired oro/nasopharyngeal swab specimens from 400 patients. The two saliva protocols demonstrated a substantial agreement when compared to the oro/nasopharyngeal swab protocol. Moreover, the positivity rate of saliva protocols increased according to the disease period. The 95 % limit of detection of one of the therefore implemented saliva protocol was determined as 9441 copies/mL. Our results support the conclusion that RNA extraction-free RT-PCR using self-collected saliva specimens is an alternative to nasopharyngeal swabs, especially in the early phase of symptom onset.
DOI: 10.1038/s41467-020-18611-5
发表时间: 2020-09-23
影响因子: 16.6
作者:
Smyrlaki I;Ekman M;Lentini A;Rufino de Sousa N;Papanicolaou N;Vondracek M;Aarum J;Safari H;Muradrasoli S;Rothfuchs AG;Albert J;Högberg B;Reinius B
通讯作者: Reinius B
DOI: 10.1016/j.cmi.2020.05.001
发表时间: 2021-02-15
影响因子: 14.2
作者:
Pasomsub, E.;Watcharananan, S. P.;Phuphuakrat, A.
通讯作者: Phuphuakrat, A.
DOI: 10.1093/cid/ciaa149
发表时间: 2020-08-01
影响因子: 11.8
作者:
To, Kelvin Kai-Wang;Tsang, Owen Tak-Yin;Yuen, Kwok-Yung
通讯作者: Yuen, Kwok-Yung
DOI: 10.1093/cid/ciaa1388
发表时间: 2021-05-25
影响因子: 11.8
作者:
Yokota, Isao;Shane, Peter Y.;Teshima, Takanori
通讯作者: Teshima, Takanori
DOI: 10.1016/j.medj.2020.12.010
发表时间: 2021-03-12
期刊: Med (New York, N.Y.)
影响因子: --
作者:
Vogels CBF;Watkins AE;Harden CA;Brackney DE;Shafer J;Wang J;Caraballo C;Kalinich CC;Ott IM;Fauver JR;Kudo E;Lu P;Venkataraman A;Tokuyama M;Moore AJ;Muenker MC;Casanovas-Massana A;Fournier J;Bermejo S;Campbell M;Datta R;Nelson A;Yale IMPACT Research Team;Dela Cruz CS;Ko AI;Iwasaki A;Krumholz HM;Matheus JD;Hui P;Liu C;Farhadian SF;Sikka R;Wyllie AL;Grubaugh ND
通讯作者: Grubaugh ND